Search Articles — Sudonull

Search Results

In this project

Compliance risks of IT products: analysis and examples

https://sudonull.com/compliance-risks-of-it-products-analysis-and-examples

Analysis of compliance risks in software operation: damage up to 5 million rubles, court cases, civil law consequences. Recommendations for IT companies to minimize losses — read the analysis.

Nvidia and SK Hynix: multi-year agreement on HBM4 memory for AI

https://sudonull.com/nvidia-and-sk-hynix-multi-year-agreement-on-hbm4-memory-for-ai

Analysis of the multi-year partnership between Nvidia and SK Hynix on the development of HBM4 and HBM4E. Who won, who lost, and why it changes AI infrastructure. Read the details.

Meta is developing a wearable AI device: Zuckerberg's strategy

https://sudonull.com/meta-is-developing-a-wearable-ai-device-zuckerberg-s-strategy

Meta has confirmed the development of a wearable AI device. We analyze the 'octopus' strategy, Hatch subscription, competition with Apple, and privacy risks. Read the details.

Vibecoding: how AI changes the role of developer and QA

https://sudonull.com/vibecoding-how-ai-changes-the-role-of-developer-and-qa

Analysis of the impact of AI assistants on the developer's workflow. Shift in roles, time economics, and code quality control. Read the breakdown.

From other projects

Smart drugs for cancer and HIV: development by Siberian scientists

https://ymaho.com/smart-drugs-for-cancer-and-hiv-development-by-siberian-scientists

Institute of the Siberian Branch of the Russian Academy of Sciences creates therapeutic oligonucleotides — molecules that switch off cancer and HIV genes. The development of phosphorylguanidines promises treatment without side effects. Learn how Russian genetic engineering bypasses Western patents.

Complaints about refusals of banking operations: 45% increase

https://ymaho.com/complaints-about-refusals-of-banking-operations-45-increase

The number of complaints about blocking of operations by banks increased by 45.2%. Find out the reasons, the impact of the Ministry of Digital Development's 'white lists' and forecasts. Read the analysis.

Gene therapy OPGx-LCA5 accepted into FDA RDEP program

https://ymaho.com/gene-therapy-opgx-lca5-accepted-into-fda-rdep-program

Learn how Opus Genetics' gene therapy OPGx-LCA5 received RDEP status from the FDA, accelerating the development of treatment for ultra-rare LCA5 blindness in children. Detailed analysis and prospects.

The Russian Government wrote off 114 billion rubles of regional debts

https://ymaho.com/the-russian-government-wrote-off-114-billion-rubles-of-regional-debts

Mishustin announced the write-off of 114 billion rubles of debts for 21 regions. Learn how reducing debt on budget loans will support the modernization of housing and communal services and business development in the constituent entities of the Russian Federation.

Apple and Intel chip manufacturing deal in the US: implications

https://ymaho.com/apple-and-intel-chip-manufacturing-deal-in-the-us-implications

Analysis of the Apple and Intel chip development and manufacturing deal in the US. Who wins, what will change for consumers, and market forecasts. Read the full review.

Smart drugs for cancer and HIV: Russian development

https://ymaho.com/smart-drugs-for-cancer-and-hiv-russian-development

Russian scientists are creating 'smart drugs' based on nucleic acids for targeted attack on cancer and HIV. Learn about the platform of the future and personalized medicine.

Fear of Public Speaking: 5 Exercises

https://ymaho.com/fear-of-public-speaking-5-exercises

Afraid of the stage? 5 psychological exercises to control glossophobia: breathing, reappraisal, and exposure. Start speaking confidently today.

FDA will approve subcutaneous Lecanemab in August 2026

https://ymaho.com/fda-will-approve-subcutaneous-lecanemab-in-august-2026

Analysis of the FDA decision postponement for Leqembi IQLIK to August 24: why this is a signal for approval, not a delay. Benefits for Alzheimer's patients and market forecast. Read key takeaways.

Trending Now